Skip to main content
SNN
NYSE Industrial Applications And Services

Smith+Nephew Acquires Integrity Orthopaedics for up to $450M, Boosting Rotator Cuff Repair Portfolio

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$33.66
Mkt Cap
$14.309B
52W Low
$23.69
52W High
$38.79
52W Position info
42% above low
Off High info
13% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

SNN sits 42% above its 52-week low of $23.69.

Summary

Smith+Nephew is acquiring Integrity Orthopaedics for an initial $225 million, with potential for up to $450 million, to enhance its shoulder repair offerings with novel rotator cuff repair technology.


Key Events · M&A and Partnerships · SNN

  • Acquisition of Integrity Orthopaedics

    Smith+Nephew will acquire Integrity Orthopaedics, an early-stage commercial developer of Tendon Seam™ rotator cuff repair technology.

  • Financial Terms

    The transaction involves an initial cash payment of US$225 million, with additional performance-based payments of up to US$225 million over five years, totaling up to US$450 million.

  • Strategic Rationale

    The acquisition is a key step in Smith+Nephew's RISE strategy, aiming to accelerate growth and establish global leadership in Sports Medicine by strengthening its shoulder repair portfolio.

  • Innovative Technology

    Tendon Seam™ offers a novel solution for rotator cuff repair, designed to significantly reduce re-tear rates and improve patient outcomes in a substantial $875 million US market.


Analysis · SNN · Industrial Applications And Services

This acquisition significantly strengthens Smith+Nephew's Sports Medicine portfolio by adding Integrity Orthopaedics' innovative Tendon Seam™ rotator cuff repair technology. The technology addresses a critical unmet need in a substantial market by aiming to reduce re-tear rates, which have historically been high. The deal, valued at up to $450 million, is a key step in the company's RISE strategy to accelerate growth and achieve leadership in Sports Medicine. The expected accretion to trading profit margin by 2028 indicates a positive long-term financial impact.

At the time of this filing, SNN was trading at $33.66 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $14.3B. The 52-week trading range was $23.69 to $38.79. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SNN - Latest Insights

SNN
Jul 27, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $31.12
Real-time Price: $32.23 info
Change: +$1.11 (+4%) info
Market Cap: $13.396B info
SNN
Jul 09, 2026, 2:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $29.95
Real-time Price: $32.23 info
Change: +$2.28 (+8%) info
Market Cap: $13.396B info
SNN
Jun 30, 2026, 6:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $30.45
Real-time Price: $32.23 info
Change: +$1.78 (+6%) info
Market Cap: $13.396B info
SNN
Jun 26, 2026, 6:15 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $30.27
Real-time Price: $32.23 info
Change: +$1.96 (+6%) info
Market Cap: $13.396B info
SNN
Jun 24, 2026, 1:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $30.43
Real-time Price: $32.23 info
Change: +$1.80 (+6%) info
Market Cap: $13.396B info